Where does Visterra, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Visterra, Inc. ranks #8,714 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Visterra, Inc. hold?

Visterra, Inc. holds 37 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Visterra, Inc.'s Innovation Score?

Visterra, Inc. has an Innovation Score of 45.6 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Visterra, Inc. focus on?

Visterra, Inc.'s top technology area is C07K (Peptides) with 36 patents, ranking #266 of 3,615 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Visterra, Inc.'s patent grant rate increasing or decreasing?

Visterra, Inc.'s recent grant velocity is +175% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Visterra, Inc.'s patents?

Visterra, Inc.'s patents average 23.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Visterra, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Visterra, Inc.

USPTO PatentsView assignee record - 37 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Visterra ranks #8,714 of 49,997 tracked US assignees by granted-patent volume, with 37 patents across 7 technology areas.

#8,714
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.6/100): 23.8
avg claims per patent: +175%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8714 · US Corporation #8,714 · 37 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 37 grants
UPPER-Q #8,714/49,997
PHOTO-FINISH Valeda
CPC-NARROW C07K · 7 areas
INNOV-PAR 45.6/100
CLAIMS-DENSE 23.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +175% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Valeda Company, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Visterra’s 45.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.6 pts (28%) Velocity 9.3 pts (20%) Breadth 9.4 pts (21%) Claim depth 14.3 pts (31%)

Qualcomm Incorporated · highest

85
ConXtech · near

46
Visterra · this assignee

46
Alpha Omega… · near

46
Mallinckrodt · near

46
Merz Pharma & KGaA · near

46
3D Lighting… · lowest

7

What this shows Visterra's Innovation Score is 45.6/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Visterra?

Each dot is one of Visterra’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Visterra’s own 23.8 claims/patent is ABOVE the 13.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Visterra vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Visterra's grants concentrate

Visterra, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 97.3% of grants classified under C07K (Peptides). Peak complete grant year is 2024 (11 grants) versus a trough of 1 in 2020. By volume, Visterra sits between Valeda Company, LLC and Wingen, LLC.

Visterra's three-year grant acceleration

Visterra, Inc. shows 14 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Valeda

37
Valencia

37
Verifood

37
Virdia

37
Vitro B de C V

37
WartsilÄ Finland…

37
Winbo-dongjian Au…

37
Wingen

37
Visterra ◀

37

What this shows Visterra holds 37 patents at rank #8,714, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Visterra

By rank, the assignees closest to #8,714 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Visterra's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Visterra, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Visterra ranks #266 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (46 here).

ConXtech, Inc. 46 Merz Pharma GmbH & Co. KGaA 46 Mallinckrodt LLC 46 Alpha Omega Engineering Ltd. 46

Visterra's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Visterra, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	5.4%
2016	2	5.4%
2018	2	5.4%
2019	2	5.4%
2020	1	2.7%
2021	7	18.9%
2022	1	2.7%
2023	2	5.4%
2024	11	29.7%
2025partial year	7	18.9%

Which technologies does Visterra, Inc. patent most?

C07K - Peptides 36

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 35

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 34

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 10

Y02A - Technologies FOR Adaptation TO Climate Change 9

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Visterra, Inc.'s patent record in context - here's where to go next.

Visterra, Inc.'s lead technology class is C07K (Peptides), 97.3% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #8,714 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Visterra, Inc. against Valeda Company, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.